New Taipei City, Taiwan, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that its chairwoman and chief executive officer, Fu Feng Kuo, has been invited to ...

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was $62,500,000, representing a 17% sequential increase from Q4 2024 [12] - Adjusted EBITDA was positive at $2,700,000 in Q1 2025, compared to a negative $4,800,000 in Q4 2024 [19] - Net loss for Q1 2025 was $500,000, or a loss of $0.01 per diluted share, compared to a net loss of $15,500,000, or a loss of $0.32 per diluted share in Q4 2024 [19] - Selling, general and administrative expenses decreased by approximately 34% sequentially to $6,500,000 in Q1 2025 [19] Business Line Data and Key Metrics Changes - Well Completions Services segment generated revenue of $20,900,000 with an average of 1.3 active pressure pumping fleets, up from $15,800,000 with 1.1 active fleets in Q4 2024 [14] - The Sands segment sold approximately 189,000 tons of sand at an average sales price of $21.49 per ton in Q1 2025, compared to 129,000 tons at $22.54 per ton in Q4 2024 [15] - Infrastructure Services segment revenue was $30,700,000 for Q1 2025, a 10% sequential increase compared to Q4 2024 [17] Market Data and Key Metrics Changes - The company anticipates increased competition in gas basins due to strong fundamental support for natural gas later in 2025 and into 2026 [11] - Macroeconomic uncertainty, tariff implications, and OPEC plus production increases have placed significant pressure on the energy market and commodity prices [15] Company Strategy and Development Direction - The company plans to evaluate strategic opportunities to add accretive assets while maintaining a strong balance sheet [5] - Following the sale of three subsidiaries, the company will focus on engineering and fiber within the Infrastructure Services segment [17] - The company aims to strategically deploy capital to grow existing businesses generating the greatest returns [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of the first quarter results and noted incremental growth in key financial metrics [10] - There is recognition of uncertainty in the market stemming from tariffs, economic conditions, and geopolitical events [10] - The company expects to manage costs effectively in response to potential weakness in utilization [27] Other Important Information - As of March 31, 2025, the company had unrestricted cash on hand of approximately $56,700,000, with total liquidity of approximately $79,400,000 [21] - After completing the sale of three subsidiaries and purchasing eight aircraft, unrestricted cash on hand increased to $135,400,000 as of May 2, 2025 [21] Q&A Session Summary Question: Can you talk about the uplift in volumes in the sand business and your outlook for the rest of the year? - Management noted strong demand in Western Canada for sand pricing and expects a stable environment to persist through 2025 [25] Question: What cost actions could be taken in the event of potential weakness in the back half of the year? - Management indicated that the biggest lever for the pressure pumping business is on staffing and repairs and maintenance, and they have historically managed costs effectively [26][27]